109 related articles for article (PubMed ID: 12803833)
1. Urinary PC-1 and N-acetyl-beta-D-glucosaminidase activity in patients with type 2 diabetes treated with metformin, gliclazide or glibenclamide.
Stefanović V; Antić S; Mitić-Zlatković M; Stojiljković S; Milojković M; Bogicević M; Vlahović P
Ann Clin Biochem; 2003 May; 40(Pt 3):232-4. PubMed ID: 12803833
[TBL] [Abstract][Full Text] [Related]
2. Urinary PC-1 activity in patients with type 1 diabetes mellitus.
Stefanović V; Rajić M; Antić S; Mitić-Zlatković M; Stojiljković S; Ivić MA; Vlahović P
Ann Clin Biochem; 2003 May; 40(Pt 3):235-8. PubMed ID: 12803834
[TBL] [Abstract][Full Text] [Related]
3. Effects of aerobic exercise on microalbuminuria and enzymuria in type 2 diabetic patients.
Lazarevic G; Antic S; Vlahovic P; Djordjevic V; Zvezdanovic L; Stefanovic V
Ren Fail; 2007; 29(2):199-205. PubMed ID: 17365936
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of the aminopeptidase N, N-acetyl-beta-D-glucosaminidase and dipeptidylpeptidase IV in evaluating tubular dysfunction in patients with glomerulopathies.
Mitic B; Lazarevic G; Vlahovic P; Rajic M; Stefanovic V
Ren Fail; 2008; 30(9):896-903. PubMed ID: 18925530
[TBL] [Abstract][Full Text] [Related]
5. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.
Stefanović V; Antić S
Clin Lab; 2004; 50(5-6):271-8. PubMed ID: 15209435
[TBL] [Abstract][Full Text] [Related]
6. Long-term therapy with addition of pioglitazone to metformin compared with the addition of gliclazide to metformin in patients with type 2 diabetes: a randomized, comparative study.
Matthews DR; Charbonnel BH; Hanefeld M; Brunetti P; Schernthaner G
Diabetes Metab Res Rev; 2005; 21(2):167-74. PubMed ID: 15386821
[TBL] [Abstract][Full Text] [Related]
7. Daily blood glucose profiles of glibenclamide and gliclazide taken once or twice daily in elderly type 2 diabetic patients.
Kigawa Y; Oba K; Futami-Suda S; Norose J; Yasuoka H; Suzuki K; Ouchi M; Watanabe K; Suzuki T; Nakano H
Geriatr Gerontol Int; 2008 Sep; 8(3):160-5. PubMed ID: 18821999
[TBL] [Abstract][Full Text] [Related]
8. Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects.
Formoso G; De Filippis EA; Michetti N; Di Fulvio P; Pandolfi A; Bucciarelli T; Ciabattoni G; Nicolucci A; Davì G; Consoli A
Diabetes Metab Res Rev; 2008; 24(3):231-7. PubMed ID: 17966969
[TBL] [Abstract][Full Text] [Related]
9. The DIACOM study (effect of DosIng frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes).
Kardas P
Diabetes Obes Metab; 2005 Nov; 7(6):722-8. PubMed ID: 16219016
[TBL] [Abstract][Full Text] [Related]
10. Glibenclamide vs gliclazide in reducing oxidative stress in patients of noninsulin dependent diabetes mellitus--a double blind randomized study.
Chugh SN; Dhawan R; Kishore K; Sharma A; Chugh K
J Assoc Physicians India; 2001 Aug; 49():803-7. PubMed ID: 11837468
[TBL] [Abstract][Full Text] [Related]
11. Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus.
Piwowar A; Knapik-Kordecka M; Fus I; Warwas M
Med Sci Monit; 2006 May; 12(5):CR210-4. PubMed ID: 16641878
[TBL] [Abstract][Full Text] [Related]
12. [Free radical scavenging activity of sulfonylureas: a clinical assessment of the effectiveness of gliclazide].
Jennings PE; Belch JJ
Ter Arkh; 2001; 73(4):27-31. PubMed ID: 11494442
[TBL] [Abstract][Full Text] [Related]
13. Are sulphonylureas all the same? A cohort study on cardiovascular and cancer-related mortality.
Monami M; Balzi D; Lamanna C; Barchielli A; Masotti G; Buiatti E; Marchionni N; Mannucci E
Diabetes Metab Res Rev; 2007 Sep; 23(6):479-84. PubMed ID: 17385195
[TBL] [Abstract][Full Text] [Related]
14. The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.
Comaschi M; Corsi A; Di Pietro C; Bellatreccia A; Mariz S;
Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):373-9. PubMed ID: 17919894
[TBL] [Abstract][Full Text] [Related]
15. Metformin decreases platelet superoxide anion production in diabetic patients.
Gargiulo P; Caccese D; Pignatelli P; Brufani C; De Vito F; Marino R; Lauro R; Violi F; Di Mario U; Sanguigni V
Diabetes Metab Res Rev; 2002; 18(2):156-9. PubMed ID: 11994908
[TBL] [Abstract][Full Text] [Related]
16. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
De Jager J; Kooy A; Lehert P; Bets D; Wulffelé MG; Teerlink T; Scheffer PG; Schalkwijk CG; Donker AJ; Stehouwer CD
J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
[TBL] [Abstract][Full Text] [Related]
17. Meal-induced platelet activation in Type 2 diabetes mellitus: effects of treatment with repaglinide and glibenclamide.
Yngen M; Ostenson CG; Hjemdahl P; Wallén NH
Diabet Med; 2006 Feb; 23(2):134-40. PubMed ID: 16433710
[TBL] [Abstract][Full Text] [Related]
18. [Serum level of retinol-binding protein 4 in obese patients with insulin resistance and in patients with type 2 diabetes treated with metformin].
Tajtáková M; Semanová Z; Ivancová G; Petrovicová J; Donicová V; Zemberová E
Vnitr Lek; 2007 Sep; 53(9):960-3. PubMed ID: 18019665
[TBL] [Abstract][Full Text] [Related]
19. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
Sharma PK; Bhansali A; Sialy R; Malhotra S; Pandhi P
Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
[TBL] [Abstract][Full Text] [Related]
20. An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin.
Barnett AH; Dreyer M; Lange P; Serdarevic-Pehar M
Diabetes Care; 2006 Aug; 29(8):1818-25. PubMed ID: 16873786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]